Pages that link to "Q35586837"

The following pages link to Aromatase and cyclooxygenases: enzymes in breast cancer (Q35586837):

Displaying 28 items.

• Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance (Q24813854) (← links)
• Aromatase expression and regulation in breast and endometrial cancer (Q26749272) (← links)
• Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery (Q28069804) (← links)
• A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study (Q28217497) (← links)
• Mechanical phenotype is important for stromal aromatase expression (Q30426266) (← links)
• Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis (Q33216006) (← links)
• Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer (Q33801778) (← links)
• Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status (Q34213076) (← links)
• Current directions for COX-2 inhibition in breast cancer (Q34498282) (← links)
• Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer (Q34612480) (← links)
• Effects of celecoxib and ly117018 combination on human breast cancer cells in vitro (Q34908885) (← links)
• Increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study (Q35121875) (← links)
• Excessive ovarian production of nerve growth factor elicits granulosa cell apoptosis by setting in motion a tumor necrosis factor α/stathmin-mediated death signaling pathway (Q35825825) (← links)
• Role of the progesterone receptor (PR) in the regulation of inflammatory response pathways and aromatase in the breast. (Q35839056) (← links)
• Aromatase, breast cancer and obesity: a complex interaction (Q36191587) (← links)
• Polyunsaturated fatty acid interactions and breast cancer incidence: a population-based case-control study on Long Island, New York (Q36396091) (← links)
• Shu-Gan-Liang-Xue Decoction Simultaneously Down-regulates Expressions of Aromatase and Steroid Sulfatase in Estrogen Receptor Positive Breast Cancer Cells (Q36654691) (← links)
• Association between urinary prostaglandin E2 metabolite and breast cancer risk: a prospective, case-cohort study of postmenopausal women (Q36916609) (← links)
• Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity (Q36948035) (← links)
• Does iron have a role in breast cancer? (Q36959432) (← links)
• Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms (Q37302387) (← links)
• Regulation of adipose oestrogen output by mechanical stress (Q37578879) (← links)
• Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome (Q40233359) (← links)
• Anti-inflammatory activity and PGE2 inhibitory properties of novel phenylcarbamoylmethyl ester-containing compounds (Q46123449) (← links)
• Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. (Q46567254) (← links)
• Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers (Q89835973) (← links)
• COX-2 Expression in Breast Carcinoma with Correlation to Clinicopathological Parameters (Q90559417) (← links)
• Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts (Q92619498) (← links)